Academics and clinicians address global issue of antibiotic resistance tonight at Citylabs 1.0

Share

Academics and clinicians are to address the global healthcare issue of antibiotic resistance at an event at Citylabs 1.0 in Manchester tonight.

Organised by the University of Manchester’s Global Health Society and ReThinkX, more than 150 people will attend the ‘sold-out’ discussion and debate about an issue the United Nations has recently declared “the greatest and most urgent risk” to public health around the world.

An expert panel of speakers will be lead the debate. They are: Professor Aneez Esmail, Professor of General Practice at the University of Manchester, Dr Will Welfare, Consultant in Communicable Disease Control, Public Health England; Dr Katie Reed a public health expert from the University of Manchester; Enrique Castro-Sanchez, from the Centre for Infection Prevention and Management (CIPM) at Imperial College, London and Dr Claas Kirchhelle, research fellow at the Wellcome Unit for the History of Medicine at the University of Oxford.

Themed ‘Antibiotic Resistance: A Global Ticking Timebomb’, the session has been organised to coincide with World Antibiotic Awareness Week.

Anne Dornan, Head of Innovation and Partnerships at Manchester Science Partnerships said: “It is really important to maintain the momentum and spotlight on the AMR debate. It is a huge global health threat and it is great to see the high level of local interest and focus on helping to address it through scientific innovation and collaboration.

“MSP has a lot of valuable resources which are committed to helping this important work – world class scientific research capabilities and also an important cluster of companies at key sites such as Alderley Park.

“Earlier this month we were privileged to welcome more than 150 of Europe’s leading scientists and companies to attend the annual BioInfect conference at Alderley Park, and we are committed to supporting  the UK response to this crucial healthcare challenge.”

Tariq Ramtoola, founder and chief executive of ReThinkX and a final year medical student at the University of Manchester, added: “As the next generation of clinicians we are aware of the ever-increasing threat of AMR, and we felt it was important to acknowledge World Antibiotic Awareness Week with this event.

“We really hope that events like this raises awareness of the issue and the urgent need to develop new antibiotics now. The practical guidance from our expert speakers will be invaluable to those of us already working in a clinical environment.”

The event this evening is held in collaboration with the Division of Population Health, Health Services Research & Primary Care, and the School of Health Sciences at the University of Manchester. It is supported by the British Society for Antimicrobial Therapy, Antibiotic Action, and Antibiotic Guardian.

ReThinkX incorporates Manchester MedX - an annual, national conference on medical technology and innovation, supported by Manchester Science Partnerships and hosted at Citylabs 1.0.